about
Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancerThe prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomyIs the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study
P50
Q33735152-80E5AD24-C05F-4FA6-A267-1FE787C0115AQ38705372-A2481756-0833-4FFF-A068-9F861B8B1299Q42700307-AB29EE1D-19B3-4AB6-83C0-D53D2434DED2Q47098945-A9038868-F098-4C97-A3C0-8D062571FC35Q55410486-B6FB5734-B3B9-4972-AF3F-A9E7B983DBFDQ91537144-8D9C512D-E250-412C-94FC-46900E3D2D75Q91592039-D1527427-BE64-4F4F-AA85-284E90A5138DQ92042944-EC782514-BE9E-412F-B8B6-9C71FC28AF2AQ93085359-38D15A6E-F40B-4C5B-B3CD-3D7E7DC38F41
P50
description
researcher
@en
wetenschapper
@nl
name
Mehmet Mutlu Meydanlı
@en
Mehmet Mutlu Meydanlı
@nl
type
label
Mehmet Mutlu Meydanlı
@en
Mehmet Mutlu Meydanlı
@nl
prefLabel
Mehmet Mutlu Meydanlı
@en
Mehmet Mutlu Meydanlı
@nl
P31
P496
0000-0001-6763-9720